ContextVision AB (publ) (OSL:CONTX)
Norway · Delayed Price · Currency is NOK 4.840
-0.040 (-0.82%)
Oct 13, 2026, 4:25 PM CET
ContextVision AB Market Cap
ContextVision AB has a market cap or net worth of 360.63 million as of October 13, 2026. It is the 32,385th most valuable company in the world and the 223rd biggest in Norway. Its market cap has increased by 0.79% in one year.
Market Cap
360.63M
Enterprise Value
291.55M
Revenue
121.88M
Global Rank
Country Rank
#223 Norway
PE Ratio
27.28
ChartMarket Cap Chart
Since March 18, 1997, ContextVision AB's market cap has increased from 296.00M to 360.63M, an increase of 21.83%. That is a compound annual growth rate of 0.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 360.63M | 12.94% |
| Dec 30, 2025 | 319.30M | -24.96% |
| Dec 30, 2024 | 425.52M | -28.57% |
| Dec 29, 2023 | 595.73M | -15.75% |
| Dec 30, 2022 | 707.14M | -44.49% |
| Dec 30, 2021 | 1.27B | -25.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 5.21B |
| Circio Holding ASA | 3.00B |
| Nordhealth AS | 2.21B |
| Thor Medical ASA | 1.84B |
| INIFY Laboratories AB | 655.60M |
| Lytix Biopharma ASA | 616.74M |
| Gentian Diagnostics ASA | 605.98M |
| Zelluna ASA | 552.42M |